RPS announces NICE accreditation
Accreditation by NICE demonstrates that RPS professional standards and guidance are developed to a high standard
The Royal Pharmaceutical Society is pleased to announce the process used to develop RPS professional guidance and standards has been accredited by the National Institute for Health and Care Excellence (NICE).
Accreditation by NICE demonstrates that RPS professional standards and guidance are developed to a high standard, supporting pharmacists delivering services and care to patients and the public.
NICE accreditation, which is seen as the ‘gold standard mark’ will be valid for five years and is retrospectively applicable to standards and guidance developed using the new 2016 NICE accredited RPS process manual. Currently, the accreditation covers the RPS Competency Framework for all Prescribers, however, as the RPS develops new standards, the NICE accreditation badge will be applied, this includes standards and guidance currently in development and any revisions or updates to existing standards and guidance.
NICE accreditation of RPS guidance:
• Helps health and social care professionals identify the most trusted sources of guidance developed using critically evaluated high quality processes
• Drives the quality of information used by health and social care professionals in decision making
• Helps to improve patient outcomes through providing robust evidence for NICE quality standards.
Alex Mackinnon, Interim CEO for the RPS says:
“We are delighted that we have achieved NICE accreditation of our processes for developing professional standards and guidance. It involves a rigorous application process and so achieving recognition is a substantial achievement. Our processes align to those of other royal colleges and demonstrates that the RPS are developing standards and guidance to the highest standards.”
NICE has accredited the process used by Royal Pharmaceutical Society to produce its professional guidance and standards. Accreditation is valid for 5 years from 17 February 2017.